Verition Fund Management
ORTX

Verition Fund Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Verition Fund Management’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,000
Closed -$25K – 2960
2022
Q3 		$25K Hold
5,000
– – ﹤0.01% 2768
2022
Q2 		$29K Hold
5,000
– – ﹤0.01% 2192
2022
Q1 		$36K Sell
5,000
-1
-0% -$10 ﹤0.01% 2528
2021
Q4 		$66K Buy
+5,001
New +$82.7K ﹤0.01% 2383
2020
Q1 		– Sell
-3,948
Closed -$543K – 1135
2019
Q4 		$543K Buy
+3,948
New +$480K 0.01% 642

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Verition Fund Management's ORTX Position: Q4 2022 in Review

Verition Fund Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2022, closing a stake of 5,000 shares — an estimated $25K sold.

Verition Fund Management first reported a position in ORTX in Q4 2019 and held it in 5 quarters. The position peaked at $543K in Q4 2019. 47 funds tracked by Wall St. Rank hold ORTX as of Q4 2022.

  • Verition Fund Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • Verition Fund Management sold 5,000 Orchard Therapeutics plc American Depositary Shares shares in Q4 2022, an estimated $25K.
  • Verition Fund Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2019 and held it in 5 quarters.
  • Verition Fund Management's Orchard Therapeutics plc American Depositary Shares position peaked at $543K in Q4 2019.
  • 47 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.